α-Adducin gene promoter DNA methylation and the risk of essential hypertension

This study was conducted to test the association between promoter DNA methylation of α-Adducin (ADD1) gene and the risk of essential hypertension (EH). A total of 150 EH patients and 100 aged- and gender-matched controls were investigated. DNA methylation levels of five cytosine-phosphate-guanine (C...

Full description

Bibliographic Details
Main Authors: Nervana M. K. Bayoumy, Mohamed M. El-Shabrawi, Ola Farouk Leheta, Hamdy Hassan Omar
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2017.1324481
_version_ 1797681553005871104
author Nervana M. K. Bayoumy
Mohamed M. El-Shabrawi
Ola Farouk Leheta
Hamdy Hassan Omar
author_facet Nervana M. K. Bayoumy
Mohamed M. El-Shabrawi
Ola Farouk Leheta
Hamdy Hassan Omar
author_sort Nervana M. K. Bayoumy
collection DOAJ
description This study was conducted to test the association between promoter DNA methylation of α-Adducin (ADD1) gene and the risk of essential hypertension (EH). A total of 150 EH patients and 100 aged- and gender-matched controls were investigated. DNA methylation levels of five cytosine-phosphate-guanine (CpG) dinucleotides on ADD1 promoter were measured employing bisulfite pyrosequencing technology. Our results showed that females have a higher ADD1 DNA methylation than males and a significantly lower CpG1 methylation level is associated with increased risk of EH among them. As for males, a significant association between lower CpG2-5 methylation levels and increased risk of EH was shown. In addition, CpG2-5 methylation was found to be a highly significant predictor for EH among males. In females, CpG1 methylation was considered a predictor of hypertension. No significant correlations were found with biochemical measures, apart from the concentration of aspartate aminotransferase which was inversely correlated with ADD1 CpG2-5 methylation levels among female controls (r = −0.703). These findings highlight that ADD1 methylation may have a contributing role in the pathogenesis of EH with varying implications for both genders.
first_indexed 2024-03-11T23:46:31Z
format Article
id doaj.art-e8addafc73d1452b9d9046e4094a76e0
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:46:31Z
publishDate 2017-11-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-e8addafc73d1452b9d9046e4094a76e02023-09-19T09:24:46ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062017-11-0139876476810.1080/10641963.2017.13244811324481α-Adducin gene promoter DNA methylation and the risk of essential hypertensionNervana M. K. Bayoumy0Mohamed M. El-Shabrawi1Ola Farouk Leheta2Hamdy Hassan Omar3College of Medicine, Center of Excellence in Thrombosis & Hemostasis, King Saud UniversitySuez Canal UniversitySuez Canal UniversitySuez Canal UniversityThis study was conducted to test the association between promoter DNA methylation of α-Adducin (ADD1) gene and the risk of essential hypertension (EH). A total of 150 EH patients and 100 aged- and gender-matched controls were investigated. DNA methylation levels of five cytosine-phosphate-guanine (CpG) dinucleotides on ADD1 promoter were measured employing bisulfite pyrosequencing technology. Our results showed that females have a higher ADD1 DNA methylation than males and a significantly lower CpG1 methylation level is associated with increased risk of EH among them. As for males, a significant association between lower CpG2-5 methylation levels and increased risk of EH was shown. In addition, CpG2-5 methylation was found to be a highly significant predictor for EH among males. In females, CpG1 methylation was considered a predictor of hypertension. No significant correlations were found with biochemical measures, apart from the concentration of aspartate aminotransferase which was inversely correlated with ADD1 CpG2-5 methylation levels among female controls (r = −0.703). These findings highlight that ADD1 methylation may have a contributing role in the pathogenesis of EH with varying implications for both genders.http://dx.doi.org/10.1080/10641963.2017.1324481cpg dinucleotidedna methylationessential hypertensionsingle nucleotide polymophismα-adducin gene
spellingShingle Nervana M. K. Bayoumy
Mohamed M. El-Shabrawi
Ola Farouk Leheta
Hamdy Hassan Omar
α-Adducin gene promoter DNA methylation and the risk of essential hypertension
Clinical and Experimental Hypertension
cpg dinucleotide
dna methylation
essential hypertension
single nucleotide polymophism
α-adducin gene
title α-Adducin gene promoter DNA methylation and the risk of essential hypertension
title_full α-Adducin gene promoter DNA methylation and the risk of essential hypertension
title_fullStr α-Adducin gene promoter DNA methylation and the risk of essential hypertension
title_full_unstemmed α-Adducin gene promoter DNA methylation and the risk of essential hypertension
title_short α-Adducin gene promoter DNA methylation and the risk of essential hypertension
title_sort α adducin gene promoter dna methylation and the risk of essential hypertension
topic cpg dinucleotide
dna methylation
essential hypertension
single nucleotide polymophism
α-adducin gene
url http://dx.doi.org/10.1080/10641963.2017.1324481
work_keys_str_mv AT nervanamkbayoumy aadducingenepromoterdnamethylationandtheriskofessentialhypertension
AT mohamedmelshabrawi aadducingenepromoterdnamethylationandtheriskofessentialhypertension
AT olafaroukleheta aadducingenepromoterdnamethylationandtheriskofessentialhypertension
AT hamdyhassanomar aadducingenepromoterdnamethylationandtheriskofessentialhypertension